Technologies for health -Bioengineering
This technology-oriented axis covers four main topics, ranging from synthetic biology to information and telecommunication technologies (ICTs) for health, surgery, and imaging.
Bioengineering includes all in vitro diagnostics and/or analysis technologies, their implantation in living organisms, and biomaterials aspects. Synthetic biology is a recent discipline that combines biology and engineering to design new living biological systems for diagnostic and therapeutic applications.
The teams involved with this field include the clinical teams at Montpellier CHU (endocrinology-diabetes, psychiatric emergencies and post emergencies, wounds, and scarring) and 31 fundamental research teams at 16 laboratories (BC2M, CBS, EuromovDMH, IGF, IGH, IGMM, INM, IRCM, IRIM, IRMB, LBN, Li2D, MMDN, PhyMedExp, Sys2Diag, TransVIHMI)
ICTs are increasingly used to help patients with chronic diseases, as well as elderly people. They make it possible to collect and track the biomarkers needed for treating patients, adapting their treatments, and patient rehabilitation. The main teams involved in this area are at Montpellier CHU (Nutrition Department, Clinical Physiology Department) and research teams such as: PhyMedExp, LBN, Epsylon, and EA MRM, as well as Institut des Mines d’Alès. Extending beyond clinical services and research laboratories, these activities are also carried out within two FHUs, ICT4CARE and RegenHab.
An e-Health chair was established in this field within the University of Montpellier Entrepreneurship Foundation.
In addition to surgical technologies that include remote operations, materials, and related equipment, the Surgery theme also covers implantable devices, functional assistance/replacement devices, and prostheses.
The Imaging theme includes all the anatomical and functional technologies used for imaging, both in vitro and in vivo.